Retrospective Multicenter Real-world Observational Study of Switching to Aflibercept 8 mg in Patients With Refractory or Dependent Exudative Age-related Macular Degeneration

NCT07423429 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nantes University Hospital